Detalhe da pesquisa
1.
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
Br J Haematol
; 204(5): 1762-1770, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500476
2.
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.
Blood
; 139(21): 3148-3158, 2022 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303070
3.
Zanubrutinib for treatment-naïve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study.
Br J Haematol
; 196(5): 1209-1218, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915592
4.
Zanubrutinib for the treatment of patients with Waldenström macroglobulinemia: 3 years of follow-up.
Blood
; 136(18): 2027-2037, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698195
5.
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL.
Blood
; 134(11): 851-859, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340982
6.
Evaluation of drug interaction potential of zanubrutinib with cocktail probes representative of CYP3A4, CYP2C9, CYP2C19, P-gp and BCRP.
Br J Clin Pharmacol
; 87(7): 2926-2936, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336408
7.
A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma.
Future Oncol
; 17(3): 255-262, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32985902
8.
A head-to-head Phase III study comparing zanubrutinib versus ibrutinib in patients with Waldenström macroglobulinemia.
Future Oncol
; 14(22): 2229-2237, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29869556
9.
A phase 1, open-label, randomized drug-drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies.
Leuk Lymphoma
; 64(2): 329-338, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480811
10.
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(13): 2305-2312, 2023 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126944
11.
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer.
J Clin Oncol
; 41(9): 1638-1645, 2023 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36921335
12.
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Blood Adv
; 7(16): 4435-4447, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276067
13.
Zanubrutinib monotherapy in relapsed/refractory indolent non-Hodgkin lymphoma.
Blood Adv
; 6(11): 3472-3479, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390135
14.
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma.
Blood Adv
; 6(6): 1629-1636, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638136
15.
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies.
Blood Adv
; 6(4): 1296-1308, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724705
16.
The potential effect of metabolic alkalosis on insulin sensitivity in an adolescent with new-onset type 1 diabetes.
Clin Case Rep
; 9(5): e03915, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34084477
17.
Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma.
Leuk Lymphoma
; 62(11): 2612-2624, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34159878
18.
Zanubrutinib for the treatment of relapsed or refractory mantle cell lymphoma.
Blood Adv
; 5(12): 2577-2585, 2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152395
19.
Why humans should not eat broom straws: Pericarditis and endocarditis.
Ann Pediatr Cardiol
; 13(2): 144-146, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641887
20.
No QTc Prolongation With Zanubrutinib: Results of Concentration-QTc Analysis From a Thorough QT Study in Healthy Subjects.
Clin Transl Sci
; 13(5): 923-931, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32144955